These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 4768684)
1. Leucopoietic effect of calusterone (7 beta, 17 alpha-dimethyltestosterone) in women with advanced breast cancer. Horn Y; Halden A; Gordan GS Scand J Haematol; 1973; 10(3):177-80. PubMed ID: 4768684 [No Abstract] [Full Text] [Related]
2. Calusterone for breast cancer. Med Lett Drugs Ther; 1973 Nov; 15(23):95. PubMed ID: 4746413 [No Abstract] [Full Text] [Related]
3. [Calusterone (7-beta, 17-alpha-dimethyltestosterone) in the palliative treatment of advanced breast cancer]. Robustelli Della Cuna G; Bernardo G; Strada MR Minerva Med; 1977 Oct; 68(52):3555-63. PubMed ID: 74052 [TBL] [Abstract][Full Text] [Related]
4. Calusterone (7beta,17alpha-dimethyltestosterone) as primary and secondary therapy of advanced breast cancer. Gordan GS; Halden A; Horn Y; Fuery JJ; Parsons RJ; Walter RM Oncology; 1973; 28(2):138-46. PubMed ID: 4583006 [No Abstract] [Full Text] [Related]
5. Calusterone. Brodkin RA; Cooper MR Ann Intern Med; 1978 Dec; 89(6):945-8. PubMed ID: 152592 [TBL] [Abstract][Full Text] [Related]
6. Effect of 7beta, 17alpha-dimethyltestosterone (calusterone) on cortisol metabolism in women with advanced breast cancer. Fukushima DK; Zumoff B; Bulkin W; Hellman L J Clin Endocrinol Metab; 1976 Jul; 43(1):38-45. PubMed ID: 133118 [TBL] [Abstract][Full Text] [Related]
7. Combined androgen and antimetabolite therapy of advanced female breast cancer. A report of the cooperative breast cancer group. Goldenberg IS; Sedransk N; Volk H; Segaloff A; Kelley RM; Haines CR Cancer; 1975 Aug; 36(2):308-10. PubMed ID: 1098764 [TBL] [Abstract][Full Text] [Related]
8. Calusterone in the therapy for advanced breast cancer. Gordan GS; Wessler S; Avioli LV JAMA; 1972 Jan; 219(4):483-90. PubMed ID: 5066641 [No Abstract] [Full Text] [Related]
9. Male breast cancer: two cases with objective regressions from calusterone (7 alpha, 17 beta-dimethyltestosterone) after failure of orchiectomy. Horn Y; Roof B Oncology; 1976; 33(4):188-91. PubMed ID: 190574 [TBL] [Abstract][Full Text] [Related]
10. 7beta,17alpha-Dimethyltestosterone (calusterone)-induced changes in the metabolism, production rate, and excretion of estrogens in women with breast cancer: a possible mechanism of action. Fishman J; Hellman L J Clin Endocrinol Metab; 1976 Feb; 42(2):365-9. PubMed ID: 131130 [TBL] [Abstract][Full Text] [Related]
11. Antitumor efficacy of 7 beta, 17 alpha-dimethyltestosterone (Calusterone) in advanced female breast cancer. Gordan GS; Halden A; Walter RM Calif Med; 1970 Sep; 113(3):1-10. PubMed ID: 5457511 [TBL] [Abstract][Full Text] [Related]
12. Combined high-dose delta1-testololactone with low-dose 5-fluorouracil in the treatment of metastatic breast cancer. Halden A; Horn Y; Walter RM; Gordan GS; Shonfeld EM Oncology; 1973; 27(6):493-501. PubMed ID: 4742676 [No Abstract] [Full Text] [Related]
13. [Trial hormone therapy of advanced breast cancers with calusterone. Preliminary study of 41 cases]. Brule G; Chauvergne J; Clavel B; Gary-Bobo J; Gurrin J; Klein T; Pommatau E Sem Hop; 1974 Dec 8-14; 50(50-51):3099-105. PubMed ID: 4377318 [No Abstract] [Full Text] [Related]
14. Hormonal therapy of breast cancer. Segaloff A Cancer; 1972 Dec; 30(6):1541-2. PubMed ID: 4641763 [No Abstract] [Full Text] [Related]
15. [Clinical considerations on the use of a new synthetic androgen, Calusterone, in the treatment of advanced breast cancer]. de Matteis A; Perrone V; Marone A Minerva Med; 1977 Jul; 68(36):2499-504. PubMed ID: 142218 [TBL] [Abstract][Full Text] [Related]
17. [Androgens in treatment of metastatic breast cancer]. Horn Y; Horn H; Gordan GS Harefuah; 1972 Dec; 83(12):584-5. PubMed ID: 4659031 [No Abstract] [Full Text] [Related]
18. Letter: Calusterone (NSC-88536) in advanced breast cancer. Falkson G; Falkson HC Cancer Treat Rep; 1976 Mar; 60(3):220-1. PubMed ID: 130973 [No Abstract] [Full Text] [Related]
19. Calusterone treatment of breast cancer. Greenspan EM JAMA; 1972 Apr; 220(4):588. PubMed ID: 5067137 [No Abstract] [Full Text] [Related]
20. Calusterone (NSC-88536): a poor substitute for fluoxy-mesterone (NSC-12165) in the treatment of advanced breast cancer. Falkson G; van Dyk JJ; van Eden EB; van der Merwe AM; FALKSON HC Cancer Chemother Rep; 1974; 58(6):939-41. PubMed ID: 4615788 [No Abstract] [Full Text] [Related] [Next] [New Search]